Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease and Hyperkalaemia

NCT04566653 · clinicaltrials.gov ↗

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease + Hyperkalaemia +/- Heart Failure

Interventions

DRUG: Calcium Polystyrene Sulphonate 15g/60 mL water
DRUG: Lokelma® 5 g/45mL water
DRUG: Lokelma® 10 g/45 mL water
DRUG: Veltassa® 8,4 g/80mL water
DRUG: Sodium Polystyrene Sulphonate 15g/60 mL water

Sponsor

AstraZeneca

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]